Brief: Dyadic Announces Expanded Licensing Agreement To Develop And Commercialize Vaccines And Biologics For African Continent
April 12 (Reuters) - Dyadic International Inc DYAI.O :
* DYADIC ANNOUNCES EXPANDED LICENSING AGREEMENT TO DEVELOP
AND
COMMERCIALIZE VACCINES AND BIOLOGICS FOR AFRICAN CONTINENT
* DYADIC INTERNATIONAL INC - WILL RECEIVE CERTAIN MARKETING
RIGHTS
AND OTHER CONSIDERATION, INCLUDING MILESTONES AND ROYALTY
PAYMENTS, FROM RUBIC
Source text for Eikon: ID:nGNX10s28g
Further company coverage: DYAI.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Dyadic International
See all newsDyadic International Inc reports results for the quarter ended June 30 - Earnings Summary
Dyadic International Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Dyadic International - Develops C1 Cell Lines And Manufactures Bundibugyo Ebolavirus Antigens Within 15 Days
Brief: Dyadic Announces Continued Listing On The Nasdaq Capital Market
Brief: Dyadic And Scripps Research Collaborate On Rapid-Response Hantavirus Antibody And Vaccine Development